JANX logo

Janux Therapeutics (JANX) Cash From Investing

Annual CFI

-$41.19 M
-$99.46 M-170.70%

December 31, 2023


Summary


Performance

JANX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherJANXcash flowmetrics:

Quarterly CFI

$12.67 M
+$203.56 M+106.64%

September 30, 2024


Summary


Performance

JANX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherJANXcash flowmetrics:

TTM CFI

-$280.82 M
+$74.13 M+20.88%

September 30, 2024


Summary


Performance

JANX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherJANXcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

JANX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-170.7%+120.6%-420.8%
3 y3 years-100.0%+106.2%+19.4%
5 y5 years-100.0%+100.0%-100.0%

JANX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-170.7%+87.9%-59.2%+106.6%-517.9%+20.9%
5 y5-year-170.7%+87.9%-59.2%+106.2%-517.9%+20.9%
alltimeall time-170.7%+87.9%-59.2%+106.2%-517.9%+20.9%

Janux Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$12.67 M(-106.6%)
-$280.82 M(-20.9%)
Jun 2024
-
-$190.88 M(+67.8%)
-$354.95 M(+142.8%)
Mar 2024
-
-$113.74 M(-1122.5%)
-$146.19 M(+254.9%)
Dec 2023
-$41.19 M(-170.7%)
$11.12 M(-118.1%)
-$41.19 M(-23.6%)
Sep 2023
-
-$61.45 M(-443.8%)
-$53.92 M(-297.6%)
Jun 2023
-
$17.87 M(-304.5%)
$27.29 M(+47.9%)
Mar 2023
-
-$8.74 M(+444.9%)
$18.46 M(-68.3%)
Dec 2022
$58.27 M
-$1.60 M(-108.1%)
$58.27 M(-13.3%)
Sep 2022
-
$19.76 M(+118.6%)
$67.20 M(-142.5%)
Jun 2022
-
$9.04 M(-70.9%)
-$158.11 M(-49.0%)
DateAnnualQuarterlyTTM
Mar 2022
-
$31.07 M(+324.1%)
-$309.74 M(-9.2%)
Dec 2021
-$340.96 M(<-9900.0%)
$7.33 M(-103.6%)
-$340.96 M(-2.1%)
Sep 2021
-
-$205.54 M(+44.1%)
-$348.29 M(+144.0%)
Jun 2021
-
-$142.60 M(>+9900.0%)
-$142.75 M(>+9900.0%)
Mar 2021
-
-$153.00 K(<-9900.0%)
-$153.00 K(<-9900.0%)
Dec 2020
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2020
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2020
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2020
-
$0.00
$0.00
Dec 2019
$0.00
-
-

FAQ

  • What is Janux Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Janux Therapeutics?
  • What is Janux Therapeutics annual CFI year-on-year change?
  • What is Janux Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Janux Therapeutics?
  • What is Janux Therapeutics quarterly CFI year-on-year change?
  • What is Janux Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Janux Therapeutics?
  • What is Janux Therapeutics TTM CFI year-on-year change?

What is Janux Therapeutics annual cash flow from investing activities?

The current annual CFI of JANX is -$41.19 M

What is the all time high annual CFI for Janux Therapeutics?

Janux Therapeutics all-time high annual cash flow from investing activities is $58.27 M

What is Janux Therapeutics annual CFI year-on-year change?

Over the past year, JANX annual cash flow from investing activities has changed by -$99.46 M (-170.70%)

What is Janux Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of JANX is $12.67 M

What is the all time high quarterly CFI for Janux Therapeutics?

Janux Therapeutics all-time high quarterly cash flow from investing activities is $31.07 M

What is Janux Therapeutics quarterly CFI year-on-year change?

Over the past year, JANX quarterly cash flow from investing activities has changed by +$74.13 M (+120.62%)

What is Janux Therapeutics TTM cash flow from investing activities?

The current TTM CFI of JANX is -$280.82 M

What is the all time high TTM CFI for Janux Therapeutics?

Janux Therapeutics all-time high TTM cash flow from investing activities is $67.20 M

What is Janux Therapeutics TTM CFI year-on-year change?

Over the past year, JANX TTM cash flow from investing activities has changed by -$226.90 M (-420.81%)